{"id":"https://openalex.org/W1973049554","doi":"https://doi.org/10.1046/j.0022-202x.2003.22113.x","title":"In Psoriasis Lesional Skin the Type I Interferon Signaling Pathway Is Activated, Whereas Interferon-\u03b1 Sensitivity Is Unaltered","display_name":"In Psoriasis Lesional Skin the Type I Interferon Signaling Pathway Is Activated, Whereas Interferon-\u03b1 Sensitivity Is Unaltered","alternate_titles":[],"publication_year":2004,"publication_date":"2004-01-01","ids":{"openalex":"https://openalex.org/W1973049554","doi":"https://doi.org/10.1046/j.0022-202x.2003.22113.x","mag":"1973049554","pmid":"https://pubmed.ncbi.nlm.nih.gov/14962089"},"language":"en","primary_location":{"id":"doi:10.1046/j.0022-202x.2003.22113.x","doi":"https://doi.org/10.1046/j.0022-202x.2003.22113.x","is_oa":true,"landing_page_url":"https://doi.org/10.1046/j.0022-202x.2003.22113.x","pdf_url":"http://www.jidonline.org/article/S0022202X15306011/pdf","source":{"id":"https://openalex.org/S28607811","display_name":"Journal of Investigative Dermatology","issn_l":"0022-202X","issn":["0022-202X","1523-1747"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Investigative Dermatology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1973049554"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"http://www.jidonline.org/article/S0022202X15306011/pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5084429665","display_name":"Leslie van der Fits","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2801952686","display_name":"Erasmus MC","ror":"https://ror.org/018906e22","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2801952686"]}],"countries":["NL"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Leslie Van der fits","raw_affiliation_strings":["Department of Immunology, Erasmus MC, University Medical Center Rotterdam, The Netherlands. c.vanderfits@erasmusmc.nl","Department of Dermatology, Erasmus MC, University Medical Center Rotterdam, the Netherlands","Department of Immunology the Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Immunology, Erasmus MC, University Medical Center Rotterdam, The Netherlands. c.vanderfits@erasmusmc.nl","institution_ids":["https://openalex.org/I2801952686"]},{"raw_affiliation_string":"Department of Dermatology, Erasmus MC, University Medical Center Rotterdam, the Netherlands","institution_ids":["https://openalex.org/I2801952686"]},{"raw_affiliation_string":"Department of Immunology the Netherlands","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080656094","display_name":"Leontine I. van der Wel","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2801952686","display_name":"Erasmus MC","ror":"https://ror.org/018906e22","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2801952686"]}],"countries":["NL"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Leontine I. Van der wel","raw_affiliation_strings":["Department of Dermatology, Erasmus MC, University Medical Center Rotterdam, the Netherlands","Department of Immunology the Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Dermatology, Erasmus MC, University Medical Center Rotterdam, the Netherlands","institution_ids":["https://openalex.org/I2801952686"]},{"raw_affiliation_string":"Department of Immunology the Netherlands","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012392552","display_name":"Jon D. Laman","orcid":"https://orcid.org/0000-0001-5085-9807","observed_orcids":["https://orcid.org/0000-0001-5085-9807"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Jon D. Laman","raw_affiliation_strings":["Department of Immunology the Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Immunology the Netherlands","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064550852","display_name":"Errol Prospero Prens","orcid":"https://orcid.org/0000-0002-8158-660X","observed_orcids":["https://orcid.org/0000-0002-8158-660X"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Errol P. Prens","raw_affiliation_strings":["Department of Immunology the Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Immunology the Netherlands","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5109238750","display_name":"Martie C. M. Verschuren","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Martie C.M. Verschuren","raw_affiliation_strings":["Department of Immunology the Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Immunology the Netherlands","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5084429665"],"corresponding_institution_ids":["https://openalex.org/I2801952686"],"apc_list":{"value":3800,"currency":"USD","value_usd":3800},"apc_paid":{"value":3800,"currency":"USD","value_usd":3800},"fwci":1.8911,"has_fulltext":true,"cited_by_count":147,"citation_normalized_percentile":{"value":0.84971465,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":92,"max":99},"biblio":{"volume":"122","issue":"1","first_page":"51","last_page":"60"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10469","display_name":"Psoriasis: Treatment and Pathogenesis","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10469","display_name":"Psoriasis: Treatment and Pathogenesis","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11668","display_name":"interferon and immune responses","score":0.0012000000569969416,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10837","display_name":"Dermatology and Skin Diseases","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/psoriasis","display_name":"psoriasis","score":0.9950000047683716},{"id":"https://openalex.org/keywords/type-i-interferon-signaling","display_name":"type I interferon signaling","score":0.9190000295639038},{"id":"https://openalex.org/keywords/type-i-interferon","display_name":"type I interferon","score":0.906000018119812},{"id":"https://openalex.org/keywords/irf2","display_name":"IRF2","score":0.9190000295639038},{"id":"https://openalex.org/keywords/keratinocytes","display_name":"keratinocytes","score":0.9259999990463257},{"id":"https://openalex.org/keywords/interferon-gamma","display_name":"interferon-gamma","score":0.7829999923706055},{"id":"https://openalex.org/keywords/keratinocyte-proliferation-and-differentiation","display_name":"keratinocyte proliferation and differentiation","score":0.7210000157356262},{"id":"https://openalex.org/keywords/skin-inflammation","display_name":"skin inflammation","score":0.7350000143051147},{"id":"https://openalex.org/keywords/psoriasis-pathogenesis","display_name":"psoriasis pathogenesis","score":0.8209999799728394}],"concepts":[{"id":"https://openalex.org/C2776178377","wikidata":"https://www.wikidata.org/wiki/Q188269","display_name":"Interferon","level":2,"score":0.8324666023254395},{"id":"https://openalex.org/C2780564577","wikidata":"https://www.wikidata.org/wiki/Q179945","display_name":"Psoriasis","level":2,"score":0.7841601371765137},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.5140405893325806},{"id":"https://openalex.org/C62478195","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signal transduction","level":2,"score":0.5005624294281006},{"id":"https://openalex.org/C2776914184","wikidata":"https://www.wikidata.org/wiki/Q101991","display_name":"Inflammation","level":2,"score":0.4711174964904785},{"id":"https://openalex.org/C2778278966","wikidata":"https://www.wikidata.org/wiki/Q6046488","display_name":"Interferon type I","level":3,"score":0.45266351103782654},{"id":"https://openalex.org/C2777074287","wikidata":"https://www.wikidata.org/wiki/Q1473931","display_name":"Keratinocyte","level":3,"score":0.44538843631744385},{"id":"https://openalex.org/C9173399","wikidata":"https://www.wikidata.org/wiki/Q6046461","display_name":"Interferon regulatory factors","level":4,"score":0.42470136284828186},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.41407814621925354},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.4073373079299927},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.336097776889801},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.18547096848487854},{"id":"https://openalex.org/C81885089","wikidata":"https://www.wikidata.org/wiki/Q189082","display_name":"Cell culture","level":2,"score":0.13070309162139893},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.12708279490470886},{"id":"https://openalex.org/C136449434","wikidata":"https://www.wikidata.org/wiki/Q428253","display_name":"Innate immune system","level":3,"score":0.09258884191513062},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.05464169383049011}],"mesh":[{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D001706","descriptor_name":"Biopsy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002467","descriptor_name":"Cell Nucleus","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D002478","descriptor_name":"Cells, Cultured","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004268","descriptor_name":"DNA-Binding Proteins","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D004268","descriptor_name":"DNA-Binding Proteins","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010641","descriptor_name":"Phenotype","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011565","descriptor_name":"Psoriasis","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D011565","descriptor_name":"Psoriasis","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D012333","descriptor_name":"RNA, Messenger","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":false},{"descriptor_ui":"D014157","descriptor_name":"Transcription Factors","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D015398","descriptor_name":"Signal Transduction","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D015398","descriptor_name":"Signal Transduction","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":true},{"descriptor_ui":"D015534","descriptor_name":"Trans-Activators","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D015603","descriptor_name":"Keratinocytes","qualifier_ui":"Q000166","qualifier_name":"cytology","is_major_topic":false},{"descriptor_ui":"D015603","descriptor_name":"Keratinocytes","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D015870","descriptor_name":"Gene Expression","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D016898","descriptor_name":"Interferon-alpha","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D016898","descriptor_name":"Interferon-alpha","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D016899","descriptor_name":"Interferon-beta","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D016899","descriptor_name":"Interferon-beta","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D050794","descriptor_name":"STAT1 Transcription Factor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D050832","descriptor_name":"Interferon-Stimulated Gene Factor 3","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D050834","descriptor_name":"Interferon-Stimulated Gene Factor 3, gamma Subunit","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D050839","descriptor_name":"Interferon Regulatory Factor-7","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":6,"locations":[{"id":"doi:10.1046/j.0022-202x.2003.22113.x","doi":"https://doi.org/10.1046/j.0022-202x.2003.22113.x","is_oa":true,"landing_page_url":"https://doi.org/10.1046/j.0022-202x.2003.22113.x","pdf_url":"http://www.jidonline.org/article/S0022202X15306011/pdf","source":{"id":"https://openalex.org/S28607811","display_name":"Journal of Investigative Dermatology","issn_l":"0022-202X","issn":["0022-202X","1523-1747"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Investigative Dermatology","raw_type":"journal-article"},{"id":"pmid:14962089","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/14962089","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of investigative dermatology","raw_type":"Journal Article"},{"id":"pmh:oai:pure.eur.nl:openaire_cris_publications/9d8f6e74-8b0d-404a-9699-2aabd5d2b21b","doi":null,"is_oa":false,"landing_page_url":"http://hdl.handle.net/1765/61804","pdf_url":null,"source":{"id":"https://openalex.org/S4306401266","display_name":"EUR Research Repository (Erasmus University Rotterdam)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I913958620","host_organization_name":"Erasmus University Rotterdam","host_organization_lineage":["https://openalex.org/I913958620"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"van der Fits, CTE, van der Wel, LI, Laman, J, Prens, E & Verschuren, MCM 2004, 'In psoriasis lesional skin the type I interferon signaling pathway is activated, whereas interferon-a sensitivity is unaltered', Journal of Investigative Dermatology, vol. 122, pp. 51-60. https://doi.org/10.1046/j.0022-202X.2003.22113.x","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:eur:oai:pure.eur.nl:publications/9d8f6e74-8b0d-404a-9699-2aabd5d2b21b","doi":null,"is_oa":false,"landing_page_url":"https://pure.eur.nl/en/publications/9d8f6e74-8b0d-404a-9699-2aabd5d2b21b","pdf_url":null,"source":{"id":"https://openalex.org/S4306401266","display_name":"EUR Research Repository (Erasmus University Rotterdam)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I913958620","host_organization_name":"Erasmus University Rotterdam","host_organization_lineage":["https://openalex.org/I913958620"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Journal of Investigative Dermatology, 122, 51 - 60. Nature Publishing Group","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:pure.rug.nl:openaire_cris_publications/50bba41e-2800-4a0f-8747-4cc20d8a1fcd","doi":null,"is_oa":true,"landing_page_url":"https://research.rug.nl/en/publications/50bba41e-2800-4a0f-8747-4cc20d8a1fcd","pdf_url":null,"source":{"id":"https://openalex.org/S4306400420","display_name":"University of Groningen research database (University of Groningen / Centre for Information Technology)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I169381384","host_organization_name":"University of Groningen","host_organization_lineage":["https://openalex.org/I169381384"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Van Der Fits , L , Van Der Wel , L I , Laman , J D , Prens , E P &amp; Verschuren , M C M 2004 , ' In Psoriasis Lesional Skin the Type I Interferon Signaling Pathway Is Activated, whereas Interferon-\u03b1 Sensitivity Is Unaltered ' , Journal of Investigative Dermatology , vol. 122 , no. 1 , pp. 51-60 . https://doi.org/10.1046/j.0022-202X.2003.22113.x","raw_type":"article"},{"id":"pmh:oai:repub.eur.nl:61804","doi":null,"is_oa":true,"landing_page_url":"http://repub.eur.nl/pub/61804","pdf_url":null,"source":{"id":"https://openalex.org/S4377196287","display_name":"RePub (Erasmus University Rotterdam)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I913958620","host_organization_name":"Erasmus University Rotterdam","host_organization_lineage":["https://openalex.org/I913958620"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"The Journal of Investigative Dermatology vol. 122 no. 1, pp. 51-60","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":{"id":"doi:10.1046/j.0022-202x.2003.22113.x","doi":"https://doi.org/10.1046/j.0022-202x.2003.22113.x","is_oa":true,"landing_page_url":"https://doi.org/10.1046/j.0022-202x.2003.22113.x","pdf_url":"http://www.jidonline.org/article/S0022202X15306011/pdf","source":{"id":"https://openalex.org/S28607811","display_name":"Journal of Investigative Dermatology","issn_l":"0022-202X","issn":["0022-202X","1523-1747"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Investigative Dermatology","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.9391000270843506,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W1973049554.pdf","grobid_xml":"https://content.openalex.org/works/W1973049554.grobid-xml"},"referenced_works_count":40,"referenced_works":["https://openalex.org/W43019232","https://openalex.org/W98489723","https://openalex.org/W299753989","https://openalex.org/W1484131343","https://openalex.org/W1964117364","https://openalex.org/W1969609823","https://openalex.org/W1970189777","https://openalex.org/W1970871223","https://openalex.org/W1976494868","https://openalex.org/W1978171344","https://openalex.org/W1989305925","https://openalex.org/W1990903687","https://openalex.org/W2003090465","https://openalex.org/W2013381987","https://openalex.org/W2029493776","https://openalex.org/W2031470419","https://openalex.org/W2039131546","https://openalex.org/W2044279486","https://openalex.org/W2048714269","https://openalex.org/W2056022468","https://openalex.org/W2061188640","https://openalex.org/W2061539584","https://openalex.org/W2066680385","https://openalex.org/W2072612890","https://openalex.org/W2074527653","https://openalex.org/W2082009343","https://openalex.org/W2108399976","https://openalex.org/W2114969819","https://openalex.org/W2119627924","https://openalex.org/W2131964341","https://openalex.org/W2133401929","https://openalex.org/W2137715338","https://openalex.org/W2143464311","https://openalex.org/W2145559734","https://openalex.org/W2153987432","https://openalex.org/W2154379321","https://openalex.org/W2159665192","https://openalex.org/W2165601614","https://openalex.org/W2410493785","https://openalex.org/W4242768823"],"related_works":["https://openalex.org/W2132041082","https://openalex.org/W2351642071","https://openalex.org/W2131964341","https://openalex.org/W2954108984","https://openalex.org/W2029493776","https://openalex.org/W7204899491","https://openalex.org/W2611303807","https://openalex.org/W2990848756","https://openalex.org/W1990903687"],"abstract_inverted_index":{"The":[0,34,48],"epidermal":[1],"phenotype":[2,38],"as":[3],"observed":[4,187],"in":[5,60,82,144,169,197],"psoriatic":[6,67,129,145,182],"skin":[7,32,90,118,130,147],"results":[8],"from":[9,119],"inflammation":[10],"and":[11,14,79],"abnormal":[12],"proliferation":[13],"terminal":[15],"differentiation":[16],"of":[17,27,36,50,58,63,74,106,200],"keratinocytes.":[18,213],"Mice":[19],"deficient":[20],"for":[21],"interferon":[22,28,45,151,191],"regulatory":[23],"factor-2,":[24],"a":[25,181],"repressor":[26],"signaling,":[29],"display":[30],"psoriasis-like":[31],"inflammation.":[33],"development":[35],"this":[37,51,96,100],"is":[39,154,193],"strictly":[40],"dependent":[41],"on":[42,177],"type":[43,138,149,166,189],"I":[44,139,150,167,190],"(interferon-alpha/beta)":[46],"signaling.":[47],"aim":[49],"study":[52],"was":[53],"to":[54,112,124,137,171,179],"assess":[55],"the":[56,61,104,114,148,186,198],"involvement":[57],"interferon-alpha/beta":[59,83],"pathogenesis":[62,199],"human":[64],"psoriasis.":[65],"In":[66],"skin,":[68],"we":[69],"measured":[70],"an":[71,134,157],"increased":[72],"expression":[73,105],"components":[75],"that":[76,108,128,143,165],"play":[77],"central":[78],"crucial":[80],"roles":[81],"signal":[84],"transduction.":[85],"Culturing":[86],"keratinocytes":[87,178],"or":[88],"healthy":[89],"biopsies":[91],"with":[92],"recombinant":[93],"interferon-alpha":[94,125,159],"stimulated":[95],"signaling":[97,152,192],"pathway;":[98],"however,":[99],"did":[101],"not":[102,132,174],"induce":[103,180],"markers":[107],"are":[109],"generally":[110],"used":[111],"define":[113],"psoriasis":[115,120],"phenotype.":[116,183],"Furthermore,":[117],"patients":[121],"responded":[122],"identically":[123],"stimulation,":[126],"demonstrating":[127],"does":[131,173],"have":[133],"aberrant":[135],"sensitivity":[136],"interferon.":[140],"We":[141],"conclude":[142],"lesional":[146],"pathway":[153],"activated,":[155],"despite":[156],"unaltered":[158],"sensitivity.":[160],"Our":[161],"data":[162],"furthermore":[163],"show":[164],"interferon,":[168],"contrast":[170],"interferon-gamma,":[172],"act":[175],"directly":[176],"Thus,":[184],"if":[185],"activated":[188],"indeed":[194],"functionally":[195],"involved":[196],"psoriasis,":[201],"its":[202],"contribution":[203],"might":[204],"be":[205],"indirect,":[206],"putatively":[207],"involving":[208],"other":[209],"cell":[210],"types":[211],"besides":[212]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1973049554","counts_by_year":[{"year":2026,"cited_by_count":4},{"year":2025,"cited_by_count":4},{"year":2024,"cited_by_count":8},{"year":2023,"cited_by_count":6},{"year":2022,"cited_by_count":9},{"year":2021,"cited_by_count":7},{"year":2020,"cited_by_count":7},{"year":2019,"cited_by_count":4},{"year":2018,"cited_by_count":12},{"year":2017,"cited_by_count":7},{"year":2016,"cited_by_count":9},{"year":2015,"cited_by_count":6},{"year":2014,"cited_by_count":2},{"year":2013,"cited_by_count":9},{"year":2012,"cited_by_count":6}],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2016-06-24T00:00:00"}
